Advances in Molecular Pathology, 2024

Advances in Molecular Pathology

reviews the year’s most important findings and updates within the field in order to provide practitioners with the current clinical information they need to improve patient outcomes.

A distinguished editorial board identifies key areas of major progress and controversy and invites preeminent specialists to contribute original articles devoted to these topics.

These insightful overviews in molecular pathology inform and enhance clinical practice by bringing concepts to a clinical level and exploring their everyday impact on patient care.

• Contains 24 articles on such topics as chronic myelomonocytic leukemia; antimicrobial resistance marker detection and clinical interpretation/limitations; DPYD and the congenital DPD deficiency; FHIR genomic operations; AI in genomics; clinical value of molecular LDTs; and more.

• Provides in-depth, clinical reviews in molecular pathology, providing actionable insights for clinical practice.

• Presents the latest information in the field under the leadership of an experienced editorial team.

  Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.